Study to Evaluate the Safety and Pharmacokinetics of ALMB-0166 in Patients With Acute Spinal Cord Injury

NCT05524103 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Spinal Cord Injury

Interventions

DRUG: ALMB-0166

Sponsor

AlaMab Therapeutics (Shanghai) Inc.